Organic OPC31 Grapeseed Extract (Healthmaxx Global) – Mislabeling (2013)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
MAX Brand Organic OPC31 Grapeseed Extract, 200 Count Capsules. Product labeling reads in part:"MAX Organic OPC31 Grapeseed Extract***NEW WITH BLUEBERRY***Dietary Supplement 200 CAPSULES***Manufactured in FDA Approved Facility for:HealthMax Products Inc. Altadena, CA 91001***".
Brand
Healthmaxx Global Inc.
Lot Codes / Batch Numbers
Lot # C1029 UPC 6 65176 33261 6
Products Sold
Lot # C1029 UPC 6 65176 33261 6
Healthmaxx Global Inc. is recalling MAX Brand Organic OPC31 Grapeseed Extract, 200 Count Capsules. Product labeling reads in part:"MA due to In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling:. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the label is not actual product contained; 2)ingredients listed are not actual ingredients contained.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, MD, NY
Page updated: Jan 6, 2026